Realtime | Geld | Brief | Zeit |
---|---|---|---|
2,520 | 2,710 | 14:50 |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
10:00 | Q-Linea AB: US Trauma Center signs commercial contract | 118 | GlobeNewswire (Europe) | Q-linea AB (publ) (OMX: QLINEA) announces adoption of the first Accelerate Pheno conversion to the ASTar system by a prominent US level 1 University Hospital Trauma Center.
The University hospital selected... ► Artikel lesen | |
18.09. | Q-Linea AB: Q-linea | Letter from the CEO | 101 | GlobeNewswire (Europe) | Q-linea AB (publ) (OMX: QLINEA) today shared a Company update.
Key messagesReiterating target of 30 - 40 ASTar units contracted by end of year 2025 with outlook for 100 - 120 by end of 2026 and exceeding... ► Artikel lesen | |
18.09. | Q-Linea AB: Q-linea resolves to carry out a rights issue of approximately SEK 322 million and announces terms | 169 | GlobeNewswire (Europe) | Q-linea AB (publ) ("Q-linea" or the "Company") (Nasdaq Stockholm: QLINEA), announces that the board of directors today has resolved to carry out a share issue of approximately SEK 322 million with preferential... ► Artikel lesen | |
05.09. | Q-Linea AB: Q-linea to initiate new clinical evaluations of ASTar in the GCC region | 302 | GlobeNewswire (Europe) | Q-linea AB (Publ) (OMX: QLINEA) announces 2 new clinical evaluations of ASTar in Saudi Arabia and Kuwait.
Q-linea, through the distributor partner AMICO Group, is moving into clinical evaluation of... ► Artikel lesen | |
14.07. | XFRA NEW INSTRUMENTS AVAILABLE ON 14.07.2025 | 453 | Xetra Newsboard | The following instruments on XETRA do have their first trading 14.07.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 14.07.2025
Aktien
1 PLK2ITR00010 Fabrity S.A.
2 SE0013512506... ► Artikel lesen | |
Q-LINEA Aktie jetzt für 0€ handeln | |||||
11.07. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 11.07.2025 | 513 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 11.07.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 11.07.2025ISIN NameCA1394811055 CAPE... ► Artikel lesen | |
11.07. | XFRA ISIN CHANGE | 345 | Xetra Newsboard | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenUS52110H1005 Lazydays Holdings Inc. 11.07.2025 US52110H2094 Lazydays Holdings Inc. 14.07.2025 Tausch 30:1US08862L1035 Beyond... ► Artikel lesen | |
11.07. | XFRA CAPITAL ADJUSTMENT INFORMATION - 11.07.2025 | 454 | Xetra Newsboard | Das Instrument 7HW SE0015812516 WYLD NETWORKS AB EQUITY wird cum Kapitalmassnahme gehandelt am 11.07.2025 und ex Kapitalmassnahme am 14.07.2025 The instrument 7HW SE0015812516 WYLD NETWORKS AB EQUITY... ► Artikel lesen | |
10.07. | Q-Linea AB: Interim report 1 January - 30 June 2025 | 221 | GlobeNewswire (Europe) | Mid-year performance on track for 2025 plan
The quarter April - June 2025Net sales amounted to SEK 1.1 (0.2) million.Operating result (EBIT) of SEK -47.3 (-65.3) million.Profit after tax amounted to... ► Artikel lesen | |
09.07. | Split and Change of ISIN for Q-Linea AB | 268 | GlobeNewswire | The company will carry out a reverse stock split in relations 1:1000. The share will be traded under new ISIN code with effect from July 14, 2025. The order book will not change.
Short... ► Artikel lesen | |
08.07. | Q-Linea AB: Q-linea AB announces timetable for reverse share split | 215 | GlobeNewswire (Europe) | At the annual general meeting of Q-linea AB (publ) (the "Company") on 26 June 2025, it was resolved to carry out a reverse share split of 1:1000, entailing that one thousand (1000) shares will be combined... ► Artikel lesen | |
19.06. | Q-Linea AB: Q-linea on track for 2025 plan | 452 | GlobeNewswire (Europe) | Q-linea AB (publ) (OMX: QLINEA) today shared a Company and Market update.
Key messagesQ2 instrument placements: Five newly-contracted units were placed, bringing the total to 14 YTD (2024: 4, Q1 2025:... ► Artikel lesen | |
23.05. | Q-Linea AB: Q-linea's board of directors proposes a reverse share split and a reduction of the share capital | 281 | GlobeNewswire (Europe) | The board of directors of Q-linea AB (publ) ("Q-linea" or the "Company") (Nasdaq Stockholm: QLINEA) proposes that the annual general meeting on 26 June 2025 resolves on a reverse share split where 1... ► Artikel lesen | |
14.04. | Q-Linea AB: Interim report 1 January - 31 March 2025 | 306 | GlobeNewswire (Europe) | Strong start to the year with accelerating momentum
First quarter: 1 January-31 March 2025Five customer contracts were signed during the quarter, three of which were in the US.Total of 9 ASTar units... ► Artikel lesen | |
25.03. | Q-Linea AB: Q-linea announces tender win in Italy | 245 | GlobeNewswire (Europe) | Q-linea AB (publ) (OMX: QLINEA) today announces the awarding of a rapid AST tender for the Naples region.
Q-linea's ASTar® platform has been selected to provide rapid AST for a network of hospitals... ► Artikel lesen | |
18.03. | Q-Linea AB: Q-linea anticipates accelerating ASTar placements through 2025 and 2026 driving revenue growth | 392 | GlobeNewswire (Europe) | Q-linea AB (publ) (OMX: QLINEA) today shared a Company and Market update.
Key messagesAnticipate total contracts for 30 - 40 ASTar instruments by end-2025; roughly 50% in USAdditional placements of... ► Artikel lesen | |
28.02. | Q-Linea AB: Year-end report 1 January - 31 December 2024 | 289 | GlobeNewswire (Europe) | Rights issue of SEK 225 million
Fourth quarter: 1 October - 31 December 2024Net sales amounted to SEK 0.2 million (0.1).The operating result totalled SEK -51.3 million (-55.4).The result for the period... ► Artikel lesen | |
05.02. | Q-Linea AB: Q-linea awarded first public tender in Belgium | 334 | GlobeNewswire (Europe) | Q-linea AB (publ) (OMX: QLINEA) today announces that the company has been awarded the tender at Cliniques Universitaires Saint-Luc in Brussels, Belgium for the ASTar® Instrument and Consumables through... ► Artikel lesen | |
31.01. | Q-Linea AB: Q-linea announces preliminary outcome of the rights issue | 629 | GlobeNewswire (Europe) | Q-linea AB (publ) ("Q-linea" or the "Company") (Nasdaq Stockholm: QLINEA) announces the preliminary outcome of the Company's rights issue of approximately SEK 225 (the "Rights Issue"), for which the... ► Artikel lesen | |
24.01. | Q-Linea AB: Continued commercial progress with US reference laboratory | 792 | GlobeNewswire (Europe) | Q-linea AB (publ) (OMX: QLINEA) today announces contract negotiations continue between Q-linea, Inc. and a large US reference laboratory, with an agreement anticipated in February 2025.
Initial sites... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FRESENIUS | 47,100 | +0,19 % | ROUNDUP/Aktien Frankfurt Schluss: Dax setzt wieder zurück - Richtungssuche | FRANKFURT (dpa-AFX) - Nach den leichten Gewinnen am Vortag hat der Dax am Donnerstag wieder den Rückwärtsgang eingelegt. Als Belastung für die hiesigen Börsen erwiesen sich zeitweise vor allem die... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 45,350 | -0,31 % | Fresenius Medical: Erste Hoffnungsschimmer im Chart | Die Fresenius-Medical-Aktie zeigt erste Anzeichen einer möglichen Bodenbildung. Kann der Widerstand bei 44,36 EUR überwunden werden Den vollständigen Artikel lesen ... ► Artikel lesen | |
CARL ZEISS MEDITEC | 44,220 | +0,91 % | Carl Zeiss Meditec, Gerresheimer, Hensoldt, Lufthansa, Puma, TeamViewer - Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
DRAEGERWERK | 64,70 | -1,52 % | Drägerwerk: Experten nehmen Gewinnschätzungen zurück | Im Bereich der Medizintechnik kommt Drägerwerk im ersten Halbjahr beim Auftragseingang auf ein Plus von 15 Prozent. Das dürfte sich im zweiten Halbjahr positiv beim Ergebnis bemerkbar machen. Belastend... ► Artikel lesen | |
MEDTRONIC | 81,45 | -0,04 % | Dividendenbekanntmachungen (26.09.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADF GROUP INC CA00089N1033 0,02 CAD 0,0123 EUR ALERUS FINANCIAL CORPORATION US01446U1034 0,21 USD 0,18 EUR ALICO INC US0162301040 0... ► Artikel lesen | |
INTUITIVE SURGICAL | 380,10 | +0,54 % | Opening Bell: Puma, Novo Nordisk, Droneshield, Rio Tinto, Robinhood, Intuitive Surgical | Alle Jahre wieder droht in den USA der Regierungsshutdown. Auch dieses Jahr. Demokraten und Republikaner haben sich noch nicht auf einen Haushalt geeinigt. Auswirkungen an der Börse waren noch nicht... ► Artikel lesen | |
THERMO FISHER | 445,60 | -0,54 % | Thermo Fisher Scientific Inc.: Thermo Fisher Scientific gibt Forschungskooperation mit AstraZeneca BioVentureHub bekannt | Der Geschäftsbereich PPD Clinical Research von Thermo Fisher Scientific, dem weltweit führenden Anbieter von wissenschaftlichen Dienstleistungen, hat heute eine neue Forschungs- und Entwicklungspartnerschaft... ► Artikel lesen | |
TELADOC HEALTH | 7,273 | +0,57 % | Down 96% From Its Highs, Is Teladoc a Hidden Bargain or a Value Trap? | ||
ROKU | 88,49 | -0,12 % | Cathie Wood's ARK ETF adjusts portfolio, buys Baidu and sells Roku stock | ||
HIMS & HERS HEALTH | 49,690 | +0,59 % | HeraMED beschleunigt seinen KI-Fahrplan - Die nächste Phase der Frauengesundheit beginnt jetzt | ||
SERNOVA BIOTHERAPEUTICS | 0,106 | -2,75 % | Sernova Biotherapeutics Announces $13 Million Debt-to-Equity Conversion Eliminating Significant Financing Overhang | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - October 1, 2025) - Sernova Biotherapeutics (TSX: SVA) (OTCQB: SEOVF) (FSE: PSH0) ("Sernova") a leading regenerative medicine company focused... ► Artikel lesen | |
ALCON | 64,52 | +0,66 % | Alcon, STAAR Surgical Announce Expiration Of HSR Waiting Period | WASHINGTON (dpa-AFX) - Alcon (ALC) and STAAR Surgical Company (STAA) announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, in connection... ► Artikel lesen | |
DEXCOM | 56,69 | 0,00 % | Forecasting The Future: 10 Analyst Projections For DexCom | ||
PRIVIA HEALTH GROUP | 24,460 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports Second Quarter 2025 Financial Results | Very Strong First Half Performance Across All Key Operating and Financial MetricsImplemented Providers +13.8% and Practice Collections +18.5% compared to 2Q'24Guidance Raised to Above High End of... ► Artikel lesen | |
GENEDX | 117,37 | 0,00 % | GeneDx announces first genomic newborn screening initiative |